Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We are pleased to announce that Prof Joel Tarning has been awarded the biennial Grahame-Smith Prize by the British Pharmacological Society for outstanding contributions to clinical pharmacology. Joel has headed MORU's Clinical Pharmacology Department since 2012. Since then, the Department has grown into large, productive group that conducts laboratory- and computer-based pharmacology research.

Profesor Joel Tarning in a laboratory. © 2020 MORU. Photographer: Gerhard Jørén

Prof David Grahame-Smith, after whom the award Joel was honoured with is named, was Professor of Pharmacology at Oxford for several decades,” said Prof Nick Day, MORU Director. “He taught me as a medical student, and both Nick White and I both worked for him as junior doctors. He was a wonderful man, very funny and deeply humane in his clinical practice. It is very fitting that Joel has won an award associated with such a giant in the field.”

Joel's research interests include infectious disease pharmacology and the use of novel pharmacometric methodologies to identify and optimise the dose in particularly vulnerable populations, such as children and pregnant women. His work on the pharmacokinetic and pharmacodynamic properties of antimalarial drugs in young children with uncomplicated and severe malaria has already had a global impact, resulting in revised WHO Guidelines for the treatment of malaria. 

"David Grahame-Smith was a wonderful man," said Prof Sir Nick White. "Nick Day and I both worked for him. He was cheerful, positive, amusing and down to earth as well as being a world leading clinical pharmacologist and a very good physician. He was also an excellent jazz pianist. It is really nice for Joel to have deservedly won this award and, in doing so, to revive his memory."

As part of his award, Joel has been invited to give a prize lecture at a future, physical meeting of the Society. Please join us in extending your congratulations to Joel.

- Text by John Bleho

Similar stories

MORU hepatitis work focusses on preventing mother-to-child transmission, high-at-risk populations, and remote communities

MORU Tropical Health Network researchers in Southeast Asia study various aspects of hepatitis B and C, infections that can lead to chronic liver diseases, and complications like liver cancer or cirrhosis. Researchers at MOCRU work on treatment for hepatitis C, a frequent opportunistic infection in HIV patients. MORU’s Clinical Pharmacology conducts two trials on possible treatments of hepatitis C. Hepatitis B is frequently transmitted from mother to child at birth, and SMRU researchers study mothers’ knowledge and behaviour, as well as prevention.

Incomplete reporting of COVID-19 disease severity criteria compromises meta-analysis

Patients affected by COVID-19 should be treated according to the severity of their disease. However, not all key national or international organisations define severity in the same way. This imprecision in severity assessment compromises the validity of some therapeutic recommendations. Using individual patient data would better guide and improve therapeutic recommendations for COVID-19.

Field evaluation of EasyScan GO: a digital malaria microscopy device

Microscopic examination of Giemsa-stained blood films is key to quantifying and detecting malaria parasites but there can be difficulties in ensuring both a high-quality manual reading and inter-reader reliability. The EasyScan GO was developed as a potential solution to this, a microscopy device using machine-learning-based image analysis for automated parasite detection and quantification.

Dengue Research Article Awarded The 2021 – 2022 Alexandre Yersin Prize for Outstanding Publications

OUCRU research article titled ‘Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes’ was recently awarded the 2021-2022 Alexandre Yersin Prize for Outstanding Publications.

Gail Carson chair of GOARN

Dr Gail Carson from the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) is nominated chair of WHO Global Outbreak Alert & Response Network (GOARN)

Enhanced vaccination against Japanese encephalitis virus could reduce encephalitis prevalence by one third in SE Asia

Encephalitis is a worldwide public health issue, with a substantially high burden among children in Southeast Asia. A large study of the causes of childhood encephalitis in SE Asia suggests that enhanced and effective vaccination against the Japanese encephalitis virus alone could reduce encephalitis prevalence by one third.